Vaccinia-based vaccines to biothreat and emerging viruses

Biotechnology & Genetic Engineering Reviews
Les P NagataDavid H Evans

Abstract

The past few years have seen a rash of emerging viral diseases, including the Ebola crisis in West Africa, the pandemic spread of chikungunya, and the recent explosion of Zika in South America. Vaccination is the most reliable and cost-effective method of control of infectious diseases, however, there is often a long delay in production and approval in getting new vaccines to market. Vaccinia was the first vaccine developed for the successful eradication of smallpox and has properties that make it attractive as a universal vaccine vector. Vaccinia can cause severe complications, particularly in immune suppressed recipients that would limit its utility, but nonreplicating and attenuated strains have been developed. Modified vaccinia Ankara is nonreplicating in human cells and can be safely given to immune suppressed individuals. Vaccinia has recently been modified for use as an oncolytic treatment for cancer therapy. These new vaccinia vectors are replicating; but have been attenuated and could prove useful as a universal vaccine carrier as many of these are in clinical trials for cancer therapy. This article reviews the development of a universal vaccinia vaccine platform for emerging diseases or biothreat agents, based on nonr...Continue Reading

References

May 1, 1992·Virology·J TartagliaM Riviere
Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·T R FuerstB Moss
Jul 1, 1987·Molecular and Cellular Biology·T R FuerstB Moss
Aug 31, 1999·The American Journal of Tropical Medicine and Hygiene·B RaengsakulrachD W Vaughn
Oct 8, 2003·Current Drug Targets. Infectious Disorders·Gerd Sutter, Caroline Staib
Aug 5, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Claudia VellozziChristine Casey
Dec 20, 2005·The Journal of General Virology·Richard H ClarkGeoffrey L Smith
Aug 31, 2006·Journal of Virology·E R TulmanD L Rock
Oct 13, 2006·Advanced Drug Delivery Reviews·Richard HarropMiles W Carroll
Apr 2, 2011·Current Gene Therapy·Carmen E GómezMariano Esteban
Nov 19, 2011·PloS One·Karen V KiblerMariano Esteban
Mar 26, 2013·Vaccine·Matthew G Cottingham, Miles W Carroll
Sep 4, 2013·The Journal of General Virology·Geoffrey L SmithRebecca P Sumner
Oct 31, 2013·Expert Review of Vaccines·Carmen Elena GómezMariano Esteban
Feb 26, 2014·Immunology and Cell Biology·Tiffany A Russell, David C Tscharke
Apr 8, 2014·Proceedings of the National Academy of Sciences of the United States of America·Sophie A ValkenburgLeo L M Poon
Apr 24, 2014·Therapeutic Advances in Vaccines·Emile F F JonkerAnna H Roukens
Jul 25, 2014·PLoS Neglected Tropical Diseases·James Weger-LucarelliJorge E Osorio
Nov 27, 2014·Human Vaccines & Immunotherapeutics·Juan García-Arriaza, Mariano Esteban
Dec 3, 2014·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Thomas P Monath, Pedro F C Vasconcelos
Apr 9, 2015·Viruses·Lucas Sánchez-SampedroMariano Esteban
Mar 31, 2016·Vaccine·Claire SmalleyDavid W C Beasley
Apr 20, 2016·JAMA : the Journal of the American Medical Association·Iain D MilliganMatthew D Snape
Aug 19, 2016·Clinical and Vaccine Immunology : CVI·Katharina B LauerThomas J Blanchard
Dec 7, 2016·The Journal of Infectious Diseases·Katrin Ramsauer, Frédéric Tangy
Mar 24, 2017·Journal of Virology·Marc SchwenekerJürgen Hausmann
Apr 4, 2017·Immunology Letters·David L VeyerGeoffrey L Smith
Jul 20, 2017·Molecular Therapy : the Journal of the American Society of Gene Therapy·Preethi EldiJohn D Hayball

❮ Previous
Next ❯

Citations

Oct 10, 2018·Expert Review of Vaccines·Natalie A ProwAndreas Suhrbier
Apr 18, 2019·Clinical and Experimental Immunology·B AfroughR Hewson
Sep 12, 2020·Nature Reviews. Microbiology·Emmanuel MargolinEdward P Rybicki
Apr 17, 2020·Expert Opinion on Biological Therapy·Adrian PelinRagunath Singaravelu
Dec 3, 2020·Pathogens·Justyna Struzik, Lidia Szulc-Dąbrowska

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.